Miriam Harris MD, MSc

Assistant Professor, General Internal Medicine

801 Massachusetts Ave | (617) 414-6625
Miriam Harris

General Internal Medicine


Clinical Addiction Research and Education Unit


Dr. Harris is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine and an addiction expert at Boston Medical Center. A graduate of McMaster University School of Medicine, Internal Medicine Residency at the University of British Columbia, General Internal Medicine Fellowship and Masters of Epidemiology at McGill University, and Addiction Medicine Fellowship at Boston University, Dr. Harris is passionate about women's health and harm reduction. Her research interests focus on the intersection of women’s health and substance use including increasing sexual, reproductive, and HIV prevention services in substance use treatment spaces, substance use treatment while pregnant and parenting, and gender-responsive harm reduction.

Clinically, she provides community-based methadone treatment at HCRC Bradston in Boston and attends on the General Medicine units and the Addiction Consult Service at Boston Medical Center.


Medicine, MD, McMaster University


Published on 10/20/2023

Harris MTH, Laks J, Hurstak E, Jain JP, Lambert AM, Maschke AD, Bagley SM, Farley J, Coffin PO, McMahan VM, Barrett C, Walley AY, Gunn CM. "If you're strung out and female, they will take advantage of you": A qualitative study exploring drug use and substance use service experiences among women in Boston and San Francisco. J Subst Use Addict Treat. 2023 Oct 20; 157:209190. PMID: 37866442.

Published on 10/1/2023

Harris M, Schiff DM, Saia K, Muftu S, Standish KR, Wachman EM. Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023). Breastfeed Med. 2023 Oct; 18(10):715-733. PMID: 37856658.

Published on 1/13/2023

Harris MT, Goldenberg S, Cui Z, Fairbairn N, Milloy MS, Hayashi K, Samet JH, Walley AY, Nolan S. Association of sex work and social-structural factors with non-fatal overdose among women who use drugs in Vancouver, Canada. Int J Drug Policy. 2023 Feb; 112:103950. PMID: 36640591.

Published on 1/9/2023

Laks J, Walley AY, Bagley SM, Barber CM, Gaeta JM, Neville LA, Peterkin AF, Rosenthal E, Saia KA, Weinstein ZM, Harris MTH. Developing a Women's Health track within addiction medicine fellowship: reflections and inspirations. Addict Sci Clin Pract. 2023 Jan 09; 18(1):3. PMID: 36617557.

Published on 2/27/2022

Gunn CM, Pankowska M, Harris M, Helsing E, Battaglia TA, Bagley SM. The representation of females in clinical trials for substance use disorder conducted in the United States (2010-19). Addiction. 2022 Oct; 117(10):2583-2590. PMID: 35165969.

Published on 2/4/2022

Peterkin AF, Abraham R, Harris MTH. A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic. J Addict Med. 2022 Sep-Oct 01; 16(5):602-605. PMID: 35120058.

Published on 1/1/2022

Harris MTH, Laks J, Stahl N, Bagley SM, Saia K, Wechsberg WM. Gender Dynamics in Substance Use and Treatment: A Women's Focused Approach. Med Clin North Am. 2022 Jan; 106(1):219-234. PMID: 34823732.

Published on 11/4/2021

Harris MTH, Lambert AM, Maschke AD, Bagley SM, Walley AY, Gunn CM. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston. J Subst Abuse Treat. 2022 04; 135:108655. PMID: 34772604.

Published on 8/30/2021

Harris MT, Seliga RK, Fairbairn N, Nolan S, Walley AY, Weinstein ZM, Turnbull J. Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing. Int J Drug Policy. 2021 12; 98:103400. PMID: 34469781.

Published on 7/16/2021

Harris MTH, Young S, Barocas J, Bayoumi AM, Caudarella A, Laurence G, Tomanovich M, Komaromy M. A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto. Public Health Rep. 2021 Sep-Oct; 136(5):532-537. PMID: 34269625.

View full list of 22 publications.